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Syllabus - Psyx 631 
Interventions— Substance Misuse
Course Meetings: MW 9:40-11:00 am, Skaggs Building #174 
Instructor: Bryan Cochran, Ph.D. Phone: 406.243.2391
Email: bryan.cochran@umontana.edu Office: Skaggs Bldg 364
Office Hours: Mon. 2:30-4, Th. 10-11:30
Accommodation of Students with Disabilities: In accordance with the University of 
Montana’s mission to provide equal educational opportunities for all students, I am 
willing to provide necessary accommodations for students with disabilities. If you 
require any accommodations, please make them known me, and I will work with the 
office of Disability Services in adapting this course.
Incompletes: Departmental and university policies regarding incompletes do not allow 
changing “incomplete” grades after one year has passed since the “I” was granted.
Academic Misconduct: All students must practice academic honesty. Academic 
misconduct is subject to an academic penalty by the course instructor and/or a 
disciplinary sanction by the University.
All students need to be familiar with the Student Conduct Code. The code is available 
for review online at http://life.umt.edu/vpsa/student_conduct.php.
Course Psyx 631 is an advanced graduate seminar course; this particular course
Description: focuses on current research on substance use disorders and related
clinical interventions.
The format of this class will be informal article/topic discussion. The 
reading list will be supplemented with case examples, which we will 
discuss in detail in class.
Objectives: By the end of this course, you will be able:
- to describe the basic pharmacological properties and 
physiological effects of drugs of abuse
- to identify and classify substance use disorders
- to formulate a treatment plan for a client with a substance use 
disorder
- to describe and apply the basic psychological treatment 
approaches for substance use disorders
- to highlight recent advances in chemical dependency treatment
Grading/ It is assumed that the best measure of your having met the objectives of
Evaluation: this course is your ability to synthesize the material you have learned and
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to present your ideas to others (orally and in writing). With this in mind, 
evaluation of your progress will be through the following components:
75% Assignments—You will complete five assignments for this course, 
all of which are listed at the end of the syllabus (there are more than five 
options for assignments, allowing you to select those most interesting to 
you). Each assignment is worth 15 points.
25% Course Participation— This is not a lecture-focused course; 
accordingly, your contributions to class (including your presence) are 
paramount.
The grading scale for this course is based on a 10-point system using 
plus/minus grades (94-100% is an A, 90-93% is an A-, 87-89% is a B+, 
etc.).
Required There is no primary text for this course. Readings from relevant journals
Materials: or other books are available through Moodle. The primary sources for
your reading list and for information presented in class are as follows:
American Psychiatric Association (2013). Diagnostic and statistical 
manual o f  mental disorders (5th ed.). Washington, DC: Author.
DiClemente, C. C. (2003). Addiction and change: How addictions 
develop and addicted people recover. New York: Guilford
Hogan, J. A., Gabrielsen, K. R., Luna, N., & Grothaus, D. (2003). 
Substance abuse prevention: The intersection o f  science and 
practice. Boston: Allyn and Bacon.
McDowell, D. M., & Spitz, H. I. (1999). Substance abuse: From 
principles to practice. Philadelphia: Brunner/Mazel.
Liska, K. (2004). Drugs and the human body with implications fo r  
society (7th ed.). Upper Saddle River, NJ: Pearson Prentice Hall.
Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping 
people change (3rd ed.). New York: Guilford.
Najavits, L. M. (2002). Seeking safety: A treatment manual fo r  PTSD and 
substance abuse. New York: Guilford.
Perrine, D. M. (1996). The chemistry o f  mind-altering drugs: History, 
pharmacology, and cultural context. Washington, DC: American 
Chemical Society.
Peterson, J. V., Nisenholz, B., & Robinson, G. (2003). A nation under the 
influence: Am erica’s addiction to alcohol. Boston: Allyn and Bacon.
[plus numerous primary journals in the field, cited in the readings section 
______________ below]__________________________________________________________
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Course Week 1 (1/27, 1/29) Psychopharmacology and the body 
Schedule:
Week 2 (2/3, 2/5) Major drugs of abuse, legal 
Week 3 (2/10*, 2/12) Major drugs of abuse, illegal 
Week 4 (2/17 is a holiday; Society’s understanding of substance use
readings discussed 2/19)
Week 5 (2/24, 2/26) Diagnosis and classification of substance 
use disorders (SUDs)
Week 6 (3/3, 3/5) Etiology, epidemiology, and dual diagnosis 
Week 7 (3/10*, 3/12) Harm reduction versus abstinence 
Week 8 (3/17, 3/19) The twelve-step model 
Week 9 (3/24, 3/26) The transtheoretical model
Week 10 (vacation week) 
Week 11 (4/7*, 4/9) Therapeutic communities, Inpatient 
treatment
Week 12 (4/14, 4/16) 
Week 13 (4/21, 4/23) 
Week 14 (4/28*, 4/30) 
Week 15 (5/5, 5/7)
Motivational interviewing 
Prevention strategies 
Considerations with specific populations 
Final Thoughts: Synthesis
* Assignments are due on these days. The final assignment is due on 5/15.
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Readings:
Week 1, Psychopharmacology and the body
Li ska, Chapter 4 (What happens to drugs after we take them)
Week 2, Major drugs of abuse, legal
Biondo, G., & Chilcoat, H.D. (2013). Discrepancies in prevalence estimates in 
two national surveys for nonmedical use of a specific opioid product versus 
any prescription pain reliever. Drag and Alcohol Dependence, 134, 396-400.
Chilcoat, H.D. (2009). An overview of the emergence of disparities in smoking 
prevalence, cessation, and adverse consequences among women. Drug and  
Alcohol Dependence, 104S, S17-S23.
Hartmann-Boyce, J., Stead, L.F., Cahill, K., & Lancaster, T. (2013). Efficacy of 
interventions to combat tobacco addiction: Cochrane update of 2012 reviews. 
Addiction, 108, 1711-1721.
Peterson, Nisenholz, & Robinson, Chapter 4 (Alcohol use, alcohol abuse, and 
health)
Roercke, M., & Rehm, J. (2013). Alcohol use disorders and mortality: A 
systematic review and meta-analysis. Addiction, 108, 1562-1578.
Week 3, Major drugs of abuse, illegal
Access the Office of National Drug Control Policy factsheets on major drug 
issues (website: http://www.whitehouse.gov/ondcp/issues-info). Read all 
ONDCP documents for the issues listed. Read through an additional layer of 
depth beyond the main pages (e.g., the FAQs).
Read the DEA factsheets on different drugs at 
http://www.justice.gov/dea/druginfo/factsheets.shtml
Winder, G.S., Stem, N., & Hosanagar, A. (2013). Are “Bath Salts” the next
generation of stimulant abuse? Journal o f  Substance Abuse Treatment, 44, 42- 
45.
Week 4, Society’s understanding of substance use
DiClemente, Chapter 1 (Models of addiction and change)
Musto, D. F. (1991). Opium, cocaine and marijuana in American history. 
Scientific American, 265, 40-47.
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Nesse, R. M., & Berridge, K. C. (1997). Psychoactive drug use in evolutionary 
perspective. Science, 278, 63-66.
Week 5, Diagnosis and classification of substance-related and addictive disorders
DSM -5- pp. 481-589
Hasin, D.S., O’Brien, C.P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A. 
... Grant, B. F. (2013). DSM-5 criteria for substance use disorders: 
Recommendations and rationale. American Journal o f  Psychiatry, 170(8), 
834-851.
McLellan, T. (2010). What is recovery? Revisiting the Betty Ford Institute 
consensus panel definition. Journal o f  Substance Abuse Treatment, 38, 200- 
201 .
Schuckit, M.A. (2013). Editor’s comer: DSM-5—Ready or not, here it comes. 
Journal o f  Studies on Alcohol and Drugs, 74.5, 661-663.
Week 6, Etiology, epidemiology, and dual diagnosis
Najavits, Chapter 1 (Overview)
Primm, A. B., Tzolova-Iontchev, & Taylor, C. M. (2000). An integrated approach 
for dually diagnosed patients in a substance abuse treatment program: Case 
presentation. Substance Abuse, 21, 121-126.
Substance Abuse and Mental Health Services Administration (2013). Results 
from the 2012 National Survey on Drug Use and Health: Summary of national 
findiings. Retrieved January 24, 2014
from http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/Nat 
ionalFindings/NSDUHresults2012.pdf
Week 7, Harm reduction versus abstinence
Hammett, T. M., Wu, Z., Due, T. T., Stephens, D., Sulllivan, S., Liu, W., Chen, 
Y., Ngu, D., & Des Jarlais, D. C. (2008). ‘Social evils’ and harm reduction: 
the evolving policy environment for human immunodeficiency vims 
prevention among injection drug users in China and Vietnam. Addiction, 103, 
137-145.
Kellogg, S. H. (2003). On “gradualism” and the building of the harm reduction- 
abstinence continuum. Journal o f  Substance Abuse Treatment, 25, 241-247.
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McKeganey, N., Morris, Z., Nealle, J., & Robertson, M. (2004). What are drug 
users looking for when they contact drug services: Abstinence or harm 
reduction? Drags: Education, Prevention and Policy, 11, 423-435.
Tatarsky, A. (2003). Harm reduction psychotherapy: Extending the reach of 
traditional substance use treatment. Journal o f  Substance Abuse Treatment,
25, 249-256.
Week 8, The twelve-step model
Kelly, J. F., & Moos, R. (2003). Dropout from 12-step self-help groups:
Prevalence, predictors, and counteracting treatment influences. Journal o f  
Substance Abuse Treatment, 24, 241-250.
Laudet, A. B. (2007). What does recovery mean to you? Lessons from the 
recovery experience for research and practice. Journal o f  Substance Abuse 
Treatment, 33, 243-256.
Magura, S. (2007). The relationship between substance user treatment and 12-step 
fellowships: Current knowledge and research questions. Substance Use & 
Misuse, 42, 343-360.
McDowell & Spitz (Chapter 20), Twelve step programs 
Week 9, The transtheoretical model
DiClemente, Chapter 2 (The process of human intentional behavior change)
Chapter 3 (The well-maintained addiction: An ending and a beginning)
Finnell, D. S. (2003). Use of the transtheoretical model for individuals with co­
occurring disorders. Community M ental Health Journal, 39, 3-15.
Week 10, Relax and enjoy your break
Week 11, Therapeutic communities and inpatient treatment
McDowell & Spitz (Chapter 24), The therapeutic community
Nielsen, A. L., & Scarpitti, F. R. (1997). Changing the behavior of substance 
abusers: Factors influencing the effectiveness of therapeutic communities. 
Journal o f  Drug Issues, 27, 279-298.
Sacks, S., Banks, S., McKendrick, K., & Sacks, J. Y. (2008). Modified
therapeutic community for co-occurring disorders: A summary of four studies. 
Journal o f  Substance Abuse Treatment, 34, 112-122.
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Sacks, S., McKendrick, K., Vazan, P., Sacks, J.Y., & Cleland, C.M. (2012). 
Modified therapeutic community aftercare for clients triply diagnosed with 
HIV/AIDS and co-occurring mental and substance use disorders. AIDS Care, 
23, 1676-1686.
Week 12, Motivational interviewing
Miller & Rollnick, Chapters 1-6 (Conversations about Change, The Spirit of 
Motivational Interviewing, The Method of Motivational Interviewing, 
Engagement and Disengagement, Listening: Understanding the Persona’s 
Dilemma, and Core Interviewing Skills: OARS)
Week 13, Prevention strategies
D ’Amico, E. J. (2005). Factors that impact adolescents’ intentions to utilize 
alcohol-related prevention services. The Journal o f  Behavioral Health 
Services & Research, 32, 332-340.
Hogan, et al. (Chapter 3), Prevention program planning
Morin, S. F., & Collins, C. (2000). Substance abuse prevention: Moving from 
science to policy. Addictive Behaviors, 25, 975-983.
Week 14, Considerations with specific populations
Campbell, C. I., & Alexander, J. A. (2002). Culturally competent treatment 
practices and ancillary service use in outpatient substance abuse treatment.
Journal o f  Substance Abuse Treatment, 22, 109-119.
Cochran, B.N., Peavy, K.M., & Robohm, J.S. (2007). Do specialized services 
exist for LGBT individuals seeking treatment for substance misuse? A study 
of available treatment programs. Substance Use & Misuse, 42, 161-176.
Messina, N., Grella, C. E., Cartier, J., & Torres, S. (2010). A randomized 
experimental study of gender-responsive substance abuse treatment for 
women in prison. Journal o f  Substance Abuse Treatment, 28, 97-107.
Sun, A. (2006). Program factors related to women’s substance abuse treatment 
retention and other outcomes: A review and critique. Journal o f  Substance 
Abuse Treatment, 30, 1-20.
Wells, K., Klap, R., Koike, A., & Sherboume, C. (2001). Ethnic disparities in 
unmet need for alcoholism, drug abuse, and mental health care. American 
Journal o f  Psychiatry, 158, 2027-2032.
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Week 15, Final Thoughts: Synthesis
Heyman, G. M. (2013). Quitting drugs: Quantitative and qualitative features. 
Annual Review o f  Clinical Psychology, 9, 29-59.
Longabaugh, R., Donovan, D. M., Kamo, M. P., McCrady, B. S., Morgenstem, J., 
& Tonigan, J. S. (2005). Active ingredients: How and why evidence-based 
alcohol behavioral treatment interventions work. Alcoholism: Clinical and 
Experimental Research, 29, 235-247.
McLellan, A. T., Carise, D., & Kleber, H. D. (2003). Can the national addiction 
treatment infrastructure support the public’s demand for quality care? Journal 
o f Substance Abuse Treatment, 25, 117-121.
Assignments:
There are five primary assignments for this course, which can be selected from the 
options below and completed in any order of your choosing. If you have an idea for an 
alternate assignment, present it to your instructor, and pending approval, it may substitute 
for one of your assignments for the course.
The due dates for each assignment are denoted by an asterisk (*) following the date in the 
course schedule; the first four assignments are due on Mondays in class, and the final 
assignment is due on the date of the final examination (Thursday, May 15).
The assignments are as follows:
A: Provide a summary (5 pages maximum) of drug trends in Montana that is based on 
web research. Suggested websites are the U.S. Drug Enforcement Administration’s 
statistics pages at http://www.justice.gov/dea/resource-center/statistics.shtml), 
SAMHSA (http://oas.samhsa.gov/states.htm ), and Montana’s Department of Public 
Health and Human Services (chemical dependency data are provided 
at http://www.dphhs.mt.gov/amdd/chemicaldependencvservices/chemicaldependencv 
data.shtml; other links may have further information). An ideal summary would also 
provide, as a comparison, data from another state. In this summary, identify the key 
problems for substance use prevention and treatment in Montana.
B: This experiential exercise is intended to give you a sense of what 12-step meetings 
are like. Find a local AA or NA meeting (directories online include for AA 
http://www.aa-montana.org/index.php?city=Missoula and for 
NA http://www.namontana.eom/l and attend it. Be sure that the meeting you select is 
an “open” meeting. Your degree of participation is up to you; the format of these 
meetings is designed to allow you to be anonymous and to participate as little or as 
much as you like. After attending the meeting, write a brief summary (3 pages
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maximum) of your experience at the meeting, and discuss what it might be like to 
seek 12-step treatment.
C: Read and summarize two articles from a recent issue of the Journal o f  Substance 
Abuse Treatment, Addiction, Substance Use and Misuse, or another major journal in 
the field. Pick articles that are of interest to you, and summarize in the following 
format:
Basic research question:
Previous research findings in this area:
Study design (brief):
Primary findings:
Implications for treatment delivery:
Each of your article summaries should be three pages or less.
D: Write a brief case study of an individual with a substance use disorder. This may be 
an actual client you have seen, if  applicable, or a hypothetical client. In your case 
study, describe the development of this person’s substance use problem, any 
comorbid conditions, a theoretical background for your case formulation (you may 
select any theory of your choosing), and a preliminary treatment plan. Limit your case 
study to eight pages. For clinical Ph.D. students, this particular assignment is 
required as one of your five.
E: In this assignment, watch a film that depicts a main character with a substance use 
disorder. Some representative films/series are Trainspotting, House o f  Cards, Blow, 
Traffic, Drugstore Cowboy, and Requiem fo r  a Dream (of course, you are free to pick 
any film with a drug theme, but please select something you have not seen before). 
Pick a theoretical perspective from which to analyze the character’s substance use 
(e.g., the transtheoretical model) and write a narrative account of the character’s 
addiction. Devise a preliminary treatment plan for this character, and discuss what 
obstacles are identified in the film that might hinder the progress of the character’s 
treatment, or what factors in place might facilitate treatment. This assignment should 
take no more than six pages.
F : Critique of readings: choose six readings that were assigned for this course, and write 
a thoughtful reaction to each of them. Your six readings should include at least three 
empirical articles. In your critique, discuss how each reading did or did not contribute 
to your understanding of substance use disorders. Please do not summarize the 
readings, but instead, formulate your own impressions and relate the readings to what 
you have learned about substance abuse from other sources. For the empirical articles, 
identify any methodological or theoretical flaws that you see, and suggest other 
studies that may answer the researchers’ original questions more effectively.
G: Do an in-depth analysis of a drug of abuse. In your overview, consider the
epidemiology of this drug’s use, the potential effects on the individual user and on 
society, and possible treatment approaches. It is expected that this review will require 
5-8 sources and will be approximately 5-6 pages.
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